Grant: Engage Grants Program
University of Waterloo
$25,000.00
Peptide functionalized graphene oxide derivatives for drug and gene delivery
EF 2017-18
Résumé
Graphene-based nanomaterials have expanded their applications to biomedicine, ranging from biosensors andimaging to scaffolds for tissue engineering to drug and gene delivery in cancer treatment. In particular,graphene oxide derivatives (GODs) are the main focus of the intensive research in the field of drug/genedelivery, due to their oxygen functionalities that make them soluble in aqueous biological media. GODs caninteract with biological molecules through both covalent and non-covalent bonds that opens up moreopportunities in for targeted drug delivery. Specific targeting, efficient drug release and intracellular traffickingare the most important requirements in a drug delivery system. The GOD delivery performance has yet to beoptimized to meet all these requirements. On the other hand, peptides are an important class of biomaterialbuilding blocks, providing unique bio-functions such as targeting, antimicrobial activity, cell penetration, andimmunotherapy. Here, we propose to explore the possibility of peptide functionalized GODs in drug and genedelivery, in terms of their functional versatility and tunability. The team, consisting of University of Waterlooresearchers and their industry partner, Zerocor, will first try to understand the interaction between peptide andGOD, and the competition among different peptides and therapeutic drugs on GOD binding. This part of studywill provide information on how to construct GOD-based drug carriers that functionalize with different typesof peptides. The physicochemical properties of the GOD-peptide/drug complexes will be investigated andcharacterized using a variety of techniques, to reveal cellular uptake mechanisms and cell membraneinteractions. The team will subsequently study the functions of a selected number of drug-peptide-GODcomplexes, in terms of tumor cell targeting, lysosomal escape and triggered drug/cargo release. Optimizedformulations of GOD/peptide/drug complexes will be tested for their stability in physiologically relevantsolutions by means of size distribution, assembly morphology, drug loading and efficacy. Eventually, themultifunctional GOD-based drug delivery system is expected to be obtained for future in vivo tests.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
520328-2017
Name nom
Chen, Pu
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
1
Application title
Peptide functionalized graphene oxide derivatives for drug and gene delivery
Keyword
NSERC
Application summary
Graphene-based nanomaterials have expanded their applications to biomedicine, ranging from biosensors andimaging to scaffolds for tissue engineering to drug and gene delivery in cancer treatment. In particular,graphene oxide derivatives (GODs) are the main focus of the intensive research in the field of drug/genedelivery, due to their oxygen functionalities that make them soluble in aqueous biological media. GODs caninteract with biological molecules through both covalent and non-covalent bonds that opens up moreopportunities in for targeted drug delivery. Specific targeting, efficient drug release and intracellular traffickingare the most important requirements in a drug delivery system. The GOD delivery performance has yet to beoptimized to meet all these requirements. On the other hand, peptides are an important class of biomaterialbuilding blocks, providing unique bio-functions such as targeting, antimicrobial activity, cell penetration, andimmunotherapy. Here, we propose to explore the possibility of peptide functionalized GODs in drug and genedelivery, in terms of their functional versatility and tunability. The team, consisting of University of Waterlooresearchers and their industry partner, Zerocor, will first try to understand the interaction between peptide andGOD, and the competition among different peptides and therapeutic drugs on GOD binding. This part of studywill provide information on how to construct GOD-based drug carriers that functionalize with different typesof peptides. The physicochemical properties of the GOD-peptide/drug complexes will be investigated andcharacterized using a variety of techniques, to reveal cellular uptake mechanisms and cell membraneinteractions. The team will subsequently study the functions of a selected number of drug-peptide-GODcomplexes, in terms of tumor cell targeting, lysosomal escape and triggered drug/cargo release. Optimizedformulations of GOD/peptide/drug complexes will be tested for their stability in physiologically relevantsolutions by means of size distribution, assembly morphology, drug loading and efficacy. Eventually, themultifunctional GOD-based drug delivery system is expected to be obtained for future in vivo tests.